Wasoff Evan L 4
4 · NEXIEN BIOPHARMA, INC. · Filed Apr 5, 2021
Insider Transaction Report
Form 4
Wasoff Evan L
Chief Financial Officer
Transactions
- Award
Common Stock
2021-04-01+1,000,000→ 2,000,000 total
Holdings
- 1,500,000
Options to purchase common stock (right to buy)
Exercise: $0.08From: 2020-08-19Exp: 2027-08-19→ Common Stock (1,500,000 underlying) - 420,000
Stock option - right to buy
Exercise: $0.54From: 2018-07-25Exp: 2025-07-25→ Common Stock (420,000 underlying) - 200,000
Stock option - right to buy
Exercise: $0.66From: 2018-10-26Exp: 2025-10-26→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]1. Issued in lieu of compensation for services.